APA (7th ed.) Citation

TTT, N., Y, Z., E, S., C, S., C, T., J, Z., . . . MD, S. (2020). HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models. The Journal of clinical investigation, 130(7), 3699. https://doi.org/10.1172/JCI129049

Chicago Style (17th ed.) Citation

TTT, Nguyen, et al. "HDAC Inhibitors Elicit Metabolic Reprogramming by Targeting Super-enhancers in Glioblastoma Models." The Journal of Clinical Investigation 130, no. 7 (2020): 3699. https://doi.org/10.1172/JCI129049.

MLA (9th ed.) Citation

TTT, Nguyen, et al. "HDAC Inhibitors Elicit Metabolic Reprogramming by Targeting Super-enhancers in Glioblastoma Models." The Journal of Clinical Investigation, vol. 130, no. 7, 2020, p. 3699, https://doi.org/10.1172/JCI129049.